LOADING
Comparing Procter & Gamble (PG) and Merck & Company (MRK) across the Consumer Staples and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | PG | MRK |
|---|---|---|
| Price | $142.71 | $113.41 |
| Change Today | +0.33% | -0.04% |
| Market Cap | $331.2B | $280.2B |
| P/E Ratio | 21.0 | 32.0 |
| Forward P/E | 20.5 | 22.0 |
| PEG Ratio | 4.11 | 5.18 |
| EPS | $6.76 | $3.55 |
| Revenue Growth (YoY) | 7.4% | 4.9% |
| Profit Margin | 19.2% | 13.6% |
| Return on Equity | 31.1% | 18.9% |
| Dividend Yield | 2.94% | 2.92% |
| Beta | 0.40 | 0.20 |
| 52-Week High | $166.21 | $124.22 |
| 52-Week Low | $135.63 | $70.74 |
| Volume | 9.6M | 5.3M |
Procter & Gamble is the larger company by market capitalization. Procter & Gamble trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Procter & Gamble offers a higher dividend yield for income investors. Procter & Gamble has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.